Recruiting Hemophilia Studies in New York
About Hemophilia Clinical Trials in New York
Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.
There are currently 2 hemophilia clinical trials recruiting participants in New York, NY. These studies are seeking a combined 178 participants. Research is being sponsored by Pfizer, Hoffmann-La Roche. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hemophilia Clinical Trials in New York — FAQ
Are there hemophilia clinical trials in New York?
Yes, there are 2 hemophilia clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What hemophilia treatments are being tested?
The 2 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.
Data updated October 14, 2026 from ClinicalTrials.gov